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Introduction: Lipemic specimens are a common and frequent, but yet unresolved problem in clinical chemistry, and may produce signifi cant inter-
ferences in the analytical results of diff erent biochemical parameters. 
Material and methods: The aim of this study was to examine the eff ect of lipid removal using ultracentrifugation of lipemic samples, on some 
routine biochemistry parameters. Among all the samples obtained daily in our laboratory, the ones which were visibly muddy were selected and 
underwent to a process of ultracentrifugation, being determined a variety of biochemical tests before and after ultracentrifugation. A total of 110 
samples were studied.
Results: We found signifi cant diff erences in all the parameters studied except for total bilirubin, glucose, gamma-glutamyl transferase (GGT) and 
aspartate aminotransferase (AST). The greatest diff erences in the parameters analyzed were found in the concentration of alanine aminotransferase 
(ALT) (7.36%) and the smallest ones in the concentration of glucose (0.014%). Clinically signifi cant interferences were found for phosphorus, creati-
nine, total protein and calcium.
Conclusion: Lipemia causes clinically signifi cant interferences for phosphorus, creatinine, total protein and calcium measurement and those inter-
ferences could be eff ectively removed by ultracentrifugation. 
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Introduction 
There is fi rm evidence that results of laboratory 
tests provide a substantial contribution to clinical 
practice. While laboratory errors are traditionally 
identifi ed with analytical problems, an extensive 
scientifi c literature now attests that most errors 
(up to 80-90%) seem to occur from the extra-analy-
tical phase.
According to the most representative studies, pre-
analytical errors represent more than half of the 
total errors which occur in the clinical laboratory 
(1,2) and within this type of errors, for its importan-
ce, it is remarkable the quality of the samples to 
analyze (3,4). Thus, the hemolysis, hyperbilirrubi-
nemia and turbidity of serum can greatly aff ect 
the accuracy of many laboratory tests (5).
The establishment of the concentration of lipids 
which produce signifi cant interference depends 
on the analyzer, reagents, analytical method and 
the concentration of interfering constituents that 
we are measuring (6). 
Lipemic sera are often found in the practice of cli-
nical laboratories and can cause signifi cant interfe-
rences in the analytical results of diff erent bioche-
mical parameters (7,8). The most common causes 
of the occurrence of lipemia are diet, alcohol inge-
stion, diabetes mellitus (9), hypertryglyceridemia, 
chronic renal failure, hypothyroidism, pancreatitis, 
multiple myeloma, primary biliary cirrhosis, lupus 
erythematosus, total parenteral nutrition (10), dru-
gs such as protease inhibitors (HIV infection), estro-
gen, oral contraceptives, etc. 
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Lipemia may interfere with tests which use trans-
mission of light as part of their measurement sys-
tem. The interference caused by lipemia is due 
mainly to three distinct mechanisms: light scatte-
ring, increasing non-aqueous phase and eff ects of 
partition between polar and non polar phases (7). 
Regarding routine clinical chemistry analyzers, the 
partitioning eff ect is the least frequent problem of 
the three potential mechanisms for interference.
The increase in non-aqueous phase will aff ect all 
methods that do not measure the activity of the 
analyte and leads to volume displacement errors, 
by reducing the water available in the volume of 
the sample. This is important because more analy-
tes are dissolved in the aqueous phase of serum/
plasma. 
Lipemia interference is also due to increased light 
scatter and the absorption of the light by the lipids 
(mainly chylomicrons and very low density lipo-
proteins) in the spectrophotometric methods. This 
phenomenon causes a decrease in the intensity of 
light reaching the solution, which will be absorbed 
(11), so the turbidity most likely aff ects the photo-
metric methods than the non-photometric meth-
ods. Both chylomicrons and VLDL particles produ-
ce this phenomenon, but in both cases the partic-
les are very heterogeneous and there is an enor-
mous variation in their size and triglyceride con-
tent, so the direct measurement of triglyceride 
content does not show good correlation with the 
phenomenon of light scattering. Moreover, the 
turbidity of the samples was very weakly correla-
ted with the concentration of triglycerides present 
in the sample (12,13). Due to the heterogeneous 
nature of lipemia there are diffi  culties in the simu-
lation in the laboratory of lipemic samples, and 
presently there are no standardized materials that 
simulate lipemia adequately. Glick and collabora-
tors (6) used already a synthetic emulsion for intra-
venous administration that is known to simulate 
lipemic samples and is called Intralipid, but Born-
horst et al. (14) in a subsequent investigation made 
it clear that we must be very cautious in interpre-
ting results interference studies in which Intralipid 
was used to simulate lipemia, since these solutions 
can not accurately mimic lipemia. This is so becau-
se both VLDL and chylomicrons represent a hete-
rogeneous group of particles that vary greatly in 
size and number, between individuals and also as 
to their content of triglycerides (15). The diff eren-
ces in the size of the particles in lipemic samples 
can greatly aff ect the eff ect of light scattering and 
the turbidity (15,16). Neither a single concentration 
may provide enough results so it is advisable to 
use a wide range of hyperlipidemic samples.
In the present study, sera with a high content of 
triglycerides (visibly turbid), but in diff erent con-
centrations were used and these samples were su-
bjected to an ultracentrifugation process to clarify 
the samples. Ultracentrifugation separates lipid 
complexes, preferentially larger, less dense (chylo-
micron) and VLDL particles, being both located on 
the top and we have determined the concentra-
tion of the diff erent routine biochemistry parame-
ters in the samples before ultracentrifugation and 
in the infranadant obtained after ultracentrifuga-
tion.
Materials and methods 
Samples
This study was performed in the Biochemistry la-
boratory of the Hospital General Yagüe of Burgos 
(Spain), from January to June of 2009. This is a ter-
tiary hospital that receive on routine analysis about 
500-600 samples daily of which 3-4 samples are 
visibly turbid (0.6-0.7%). 
Among all of these routine samples, we selected 
the samples which were visibly turbid and after 
their centrifugation (1.500 x g for 15 minutes) three 
aliquots were obtained, one of which was used to 
determine appropriate parameters, another was 
further subjected to the ultracentrifugation proce-
ss, after which the same biochemical determinati-
ons from the previous case were repeated. The third 
aliquot was frozen at -80 °C for possible checks. A 
total of 110 samples were studied, although in some 
of them there was not enough amount of sample 
to perform the biochemical analysis of all the
diff erent parameters. The process by which samples 
were subjected involved ultracentrifugation at 
40.000 x g and +4 °C, without adjustment of densi-
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ty (d = 1.006 kg/L) for 18 hours in a Centrikon 
T-1080 Ultracentrifuge (Kontron AG, Switzerland). 
Ultracentrifugation can achieve greater speed of 
rotation than high speed centrifugation, and the-
refore generate higher centrifugal forces.
Methods
The supernatant was carefully separated and bio-
chemical determinations were made in the infra-
natant. The analytical parameters determined (in 
the fi rst aliquot and in the aliquot subjected to ul-
tracentrifugation) were the following: cholesterol, 
triglycerides, alkaline phosphatase (ALP), gamma-
glutamyl transferase (GGT), aspartate amino trans-
ferase (AST), alanine aminotransferase (ALT), lacta-
te dehydrogenase (LD), total bilirubin, total cal-
cium, creatinine, phosphorus, glucose, iron, urea, 
uric acid and total protein in a Hitachi Modular D 
and P (Roche Diagnostics, Mannheim, Germany). 
Analytical methods employed for each of the bio-
chemical parameters that have been determined 
are presented in table 1. The maximum number of 
samples analyzed was 110 for Uric acid, Urea and 
Total Protein and the minimum number was 93 for 
Iron.
Statistical analysis
Normality was tested for each variable. Variables 
that were distributed normally were presented with 
arithmetic mean ± standard deviation. Variable (tri-
glycerides) that was not distributed normally was 
presented with median and interquartile range.
To compare the average values of the various pa-
rameters measured before and after being subjec-
ted to ultracentrifugation parametric Student t test 
for paired data (for normally distributed data) and 
nonparametric Wilcoxon test (for triglycerides) 
were used. 
Percentage of change was calculated for each 
analyte before and after centrifugation and com-
pared to desirable inaccuracy according to data 
published in the literature (17). 




Creatinine Jaff é (kinetic white) 
Urate Peroxidase uricase 
Aspartate aminotransferase (AST) IFCC (pyridoxal phosphate)
Alanine aminotransferase (ALT) IFCC (pyridoxal phosphate)




Alkaline phosphatase (ALP) Rosalki
Creatine kinase (CK) DGKC




Iron Ferrozine without deproteinization
IFCC - International Federation of Clinical Chemistry; DPD - 2,5-dichlorophenyldiazonium tetrafl uoroborate; 
GPD-PAP - Glicerol phosphate-dehidrogenase-peroxidase; CHOP-PAP - Cholesterol oxidase –peroxidase; DGKC 
- Deutsche Gesellschaft für klinische Chemie; 
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Statistical analysis was performed using SPSS sof-
tware (SPSS Inc., Chicago, Illinois, USA).
Results
The results of the various serum parameters mea-
sured by spectrophotometric methods before and 
after samples were subjected to ultracentrifuga-
tion are presented in Table 2.  
In this table the mean concentration before and 
after ultracentrifugation and the number of speci-
mens analyzed is expressed as well as the median, 
the standard deviation or Q1-Q3 for each parame-
ter, the percentage change in the mean values af-
ter samples being subjected to ultracentrifugation, 
the intraindividual variation coeffi  cient and the 
desirable inaccuracy for each of the parameters, 
according to data published in the literature (17). 
Aside from the expected changes in the concen-
tration of triglycerides (20.67%) and cholesterol 
(7.50 %), the greatest diff erence in the parameters 
analyzed was found for ALT (7.36%). Minor chan-
ges were found in the concentration of phospho-
rus (5.20%), creatinine (4.25%), GGT (3.04%), urea 
(2.24%), iron (1.98%), ALP (1.88%), total protein 
(1.75%), uric acid (1.47%), total bilirubin (1.24%), cal-
cium (1.16%) and AST (1.14%). Glucose with less than 
1% diff erence was the least aff ected parameter.
When the values of various parameters measured 
before and after ultracentrifugation were compa-
red, signifi cant diff erences were observed in all ca-
ses except for total bilirubin (P = 0.881), GGT (P = 
0.326), glucose (P = 0.972) and AST (P = 0.609). 
In the rest of the parameters we obtained signifi -
cant diff erences with a signifi cance level of P 
<0.001 except for calcium which had a signifi cance 
level of P < 0.005 and urea with P < 0.05. 
TABLE 2. Variation in the concentration of the diff erent parameters measured by spectrophotometry before and after samples were 
subjected to ultracentrifugation






Cholesterol (mmol/L) 106 6.93 ± 2.26 6.40 ± 2.16 7.5 5.4 2.7
Triglycerides (mmol/L) 108 5.71 (5.11-6.79) ** 4.56 (3.95-5.56) ** 20.7 20.9 10.7
Total bilirubin (mmol/L) 101 16.41 ± 39.11 16.20 ± 39.40 1.24 23.9 11.9
Calcium (mmol/L) 99 2.38 ± 0.18 2.41 ± 0.14 1.16 1.9 0.95
Creatinine (µmol/L) 109 114.35 ± 131.22 119.21 ± 134.12 4.25 5.3 3.79
Phosphorus (mmol/L) 97 1.19 ± 0.37 1.26 ± 0.40 5.2 8.5 4.3
Glucose (mmol/L) 110 7.37 ± 4.07 7.37 ± 4.01 0.014 5.7 2.9
Iron (µmol/L) 93 15.57 ± 7.73 15.88 ± 7.73 1.98 26.5 13.3
Urea (mmol/L) 110 7.37 ± 6.68 7.53 ± 6.55 2.24 12.3 6.2
Urate (µmol/L) 110 383.97 ± 126.9 389.65 ± 126.25 1.47 9 4.5
Total protein (g/L) 110 70.74 ± 8.18 71.99 ± 8.26 1.75 2.7 1.4
ALP (U/L) 108 221 ± 111.6 225 ± 111.7 1.88 6.4 3.2
GGT (UI/L) 106 135 ± 158.2 139 ± 167.7 3.65 13.8 6.9
AST (U/L) 107 35 ± 48.9 35 ± 48.4 1.14 11.9 5.95
ALT (U/L) 106 44 ± 55.8 40 ± 46.9 7.36 24.3 12.45
LD (U/L) 108 361 ± 229.6 314 ± 190.2 1.28 8.6 4.3
Data are presented with arithmetic mean ± standard deviation.
* According to Westgard (17)
** Median (interquartile range)
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Discussion
In this study we have found signifi cant diff erences 
before and after ultracentrifugation in lipemic sera 
in all parameters studied except for total bilirubin, 
GGT, glucose and AST. 
Studies by Brady et al. and Jabbar et al. show that 
the majority of analytes are aff ected by hyperlipi-
demia (18,19). In this sense, The Committee for the 
Implementation of the French Society of Clinical 
Biology (SFBC) (20) decided to study the interfe-
rence problems caused by “visible” interferences - 
bilirubin, hemolysis and turbidity, and their eff ect 
in 20 biochemical tests (13 of which were substra-
tes and 7 enzymes). These parameters were mea-
sured in the 15 Autoanalyzers more representati-
ves of those found on the French market. To cause 
turbidity in the serum, Intralipid was added. The 
diff erent tests were not aff ected with equal inten-
sity. Substances with higher interference by turbi-
dity were, in this order, uric acid, iron, total protein 
and bilirubin. 
Also, Steen et al. (21) conducted a multicenter analy-
sis of 16 Dutch clinical laboratories, evaluating the 
interference caused by hemolysis, hyperbilirubine-
mia and lipemia in the determination of 32 diff e-
rent analytes. On the basis of biological variation 
these authors suggested a cut-off  value above 
which, clinically signifi cant interference exists. 
They found clinically signifi cant interference from 
lipemia in 12 of the 32 analytes studied. The expe-
riment was carried out also with test samples from 
a pool spiked with 10% Intralipid.
An important concept to consider when we refer 
to interference in biochemical analysis is that we 
must diff erentiate between “analytically signifi cant 
interferences” and “clinically signifi cant interferen-
ces”. The fi rst are those that according to the IUPAC 
(International Union of Pure and Applied Chemi-
stry) produce in an analytical procedure a syste-
matic error greater than three times the standard 
deviation found in a study of precision for a given 
concentration of the component under study (22) 
and produce a systematic error greater than the 
one justifi ed by the imprecision or the uncertainty 
of the method. 
The “clinically signifi cant interferences” are those 
that generally lead to signifi cant errors in the inter-
pretation of laboratory results. These interferences 
should be considered as such when, in relative 
terms, the value of the interference is greater than 
half the intraindividual biological coeffi  cient of va-
riation (17,23).
According to Glick the diff erences between the 
samples with or without interference must be be-
low 3%, when assessing the result of a sample for 
a short term follows up, and to monitoring a pa-
tient for a long-time this author can accept a maxi-
mum range equal to the objective of inaccuracy of 
the method, except for ALT, CK and GGT in which 
the change should not exceed 10%. When the re-
sult is to be used in the screening of population it 
is consistent to choose the total error as the limit 
of permissiveness, except for GGT and triglycerides 
in which is preferable to choose higher standards. 
In the study under consideration the diff erences 
between the two measurements, native and ultra-
centrifugated samples did not exceed 10% and the 
total maximum error allowed has not been excee-
ded in any of the techniques.
We found clinically signifi cant interferences accor-
ding to biological coeffi  cient of variation and 
objectives of inaccuracy (17) for the following pa-
rameters: phosphorus, creatinine, total protein and 
calcium (Table 2).
Methods for removal lipids of the samples include 
ultracentrifugation (the gold standard), high speed 
centrifugation and lipid clearing agents, mainly Li-
poclear. Vermeer et al. (24) compared reducing li-
pemia by high speed centrifugation or treating 
sera with Lipoclear and irrespective of the metho-
dology used found excellent recovery in most of ca-
ses, but using high speed centrifugation the reco-
very was unacceptable for total bilirubin and CRP 
and using Lipoclear the recovery was inacceptable 
for GGT, HDL cholesterol, cholesterol and CRP.
On the other hand, Anderson et al. (25) using a clari-
fying agent Lipoclear, found no critical diff erences 
in the concentration of the analytes studied before 
and after treatment with Lipoclear, except in the 
concentration of total protein, phosphorus and an 
expected fall for cholesterol and triglycerides. 
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Moreover, there are too few studies using native li-
pemic samples, but Dimeski et al. (26) in a recent 
study evaluated a procedure with 10 native sam-
ple pools for the capacity to reduce lipid concen-
tration using a speed micro centrifuge compared 
with an ultracentrifuge. It appears that the high 
speed centrifugation procedure used by Dimeski 
et al. (26) is superior to the one utilized by Vermeer 
et al. (24), perhaps by the higher centrifugation 
speed and the double centrifugation process used 
by Dimeski. Data obtained by Dimeski et al. (26) con-
fi rm that when several re-centrifugation steps are 
performed, high speed centrifugation is almost as 
eff ective as ultracentrifugation in lipid reduction.
The main limitation of our study is that we have 
used ultracentrifugation to reduce lipemia and 
many laboratories do not have ultracentrifuges, 
moreover this is a very long procedure for trea-
tment of samples that come, in many occasions, 
from Emergency Services.  
Further studies are needed that compare ultracen-
trifugation methods with high speed centrifugati-
on methods and the use of Lipoclear. It is neces-
sary to correlate these methods with serum indi-
ces obtained in the autoanalyzers (based on alter-
native photometric wavelength measurements). 
This is so because most laboratories rely on the li-
pemic index and manufacturer method recom-
mendations for acceptable limits that are almost 
always established by using emulsions spiked sam-
ples, and emulsions do not behave in the same 
way as native lipemic samples.
Conclusion
Although the percentage change in the concen-
tration of diff erent analytes before and after ultra-
centrifugation in hyperlipidemic sera never excee-
ded the total allowable error, signifi cant diff eren-
ces in all parameters were found except for total 
bilirubin, glucose, GGT and AST and a variation 
that exceeds the allowed desirable inaccuracy and 
therefore clinically signifi cant interferences in 
phosphorus, creatinine, total protein and calcium.
This gives an idea of the importance of proper 
treat ment of lipemic samples and the signifi cance 
of interferences in preanalytical phase and in the 
whole process of biochemical analysis of serum 
samples.
Potential Confl icts of Interest: None declared.
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Interferencije uslijed lipemije pri rutinskom određivanju biokemijskih 
parametara
Sažetak
Uvod: Lipemični su uzorci uobičajena i česta pojava, no još uvijek predstavljaju neriješen problem u kliničkoj kemiji i mogu prouzročiti statistički 
značajne interferencije u rezultatima analitičkih ispitivanja različitih biokemijskih parametara.
Materijali i metode: Cilj ovog istraživanja bio je ispitati učinak uklanjanja lipida iz lipemičnih uzoraka ultracentrifugiranjem kod određivanja 
nekih rutinskih biokemijskih parametara. Između svih uzoraka koji dnevno pristižu u naš laboratorij odabrali smo one koji su vizualno bili zamu-
ćeni te ih podvrgnuli procesu ultracentrifugiranja. Na njima smo izveli različita biokemijska ispitivanja prije i nakon ultracentrifugiranja. Proučili 
smo ukupno 100 uzoraka.
Rezultati: Pronađena je značajna statistička razlika kod svih ispitanih parametara osim kod određivanja koncentracije ukupnog bilirubina, ak-
tivnosti gama-glutamil-transferaze (GGT), glukoze i aspartat-aminotransferaze (AST). Najveća je razlika primijećena kod aktivnosti alanin-ami-
notrabsferaze (ALT) (7,36%), a najmanja kod koncentracije glukoze (0,014%). Klinički značajne interferencije primijećene su kod koncentracija 
fosfora, kreatinina, ukupnih proteina i kalcija.
Zaključak: Lipemija uzrokuje klinički značajne interferencije za određivanje koncentracije fosfora, kreatinina, ukupnog proteina i kalcija. Te se 
interferencije mogu uspješno ukloniti primjenom ultracentrifugiranja.
Ključne riječi: lipemija; ultracentrifugiranje; biokemijsko ispitivanje; interferencije
